Details about Rena Conti
Access statistics for papers by Rena Conti.
Last updated 2025-02-01. Update your information in the RePEc Author Service.
Short-id: pco1176
Jump to Journal Articles Chapters
Working Papers
2021
- Common Agent or Double Agent? Pharmacy Benefit Managers in the Prescription Drug Market
NBER Working Papers, National Bureau of Economic Research, Inc
2020
- Valuing Rare Pediatric Drugs: An Economics Perspective
NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
2019
- Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets
NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
- The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
- The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration
NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
2017
- The Generic Drug User Fee Amendments: An Economic Perspective
NBER Working Papers, National Bureau of Economic Research, Inc View citations (2)
- The Landscape of US Generic Prescription Drug Markets, 2004-2016
NBER Working Papers, National Bureau of Economic Research, Inc View citations (11)
2015
- Pricing in the Market for Anticancer Drugs
NBER Working Papers, National Bureau of Economic Research, Inc View citations (41)
See also Journal Article Pricing in the Market for Anticancer Drugs, Journal of Economic Perspectives, American Economic Association (2015) View citations (41) (2015)
2014
- Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007
NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
See also Chapter Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001–2007, NBER Chapters, National Bureau of Economic Research, Inc (2016) View citations (2) (2016)
2011
- The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
2006
- Early Retirement and Public Disability Insurance Applications: Exploring the Impact of Depression
NBER Working Papers, National Bureau of Economic Research, Inc View citations (12)
Journal Articles
2024
- Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices
Management Science, 2024, 70, (10), 6483-6501
2015
- Pricing in the Market for Anticancer Drugs
Journal of Economic Perspectives, 2015, 29, (1), 139-62 View citations (41)
See also Working Paper Pricing in the Market for Anticancer Drugs, NBER Working Papers (2015) View citations (41) (2015)
Chapters
2016
- Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001–2007
A chapter in Measuring and Modeling Health Care Costs, 2016, pp 273-321 View citations (2)
See also Working Paper Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007, National Bureau of Economic Research, Inc (2014) View citations (6) (2014)
2012
- How do Initial Signals of Quality Influence the Diffusion of New Medical Products? The Case of New Cancer Drug Treatments
A chapter in The Economics of Medical Technology, 2012, pp 123-148
2009
- Early Retirement and DI/SSI Applications: Exploring the Impact of Depression
A chapter in Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly, 2009, pp 381-408
|
The links between different versions of a paper are constructed automatically by matching on the titles.
Please contact if a link is incorrect.
Use this form
to add links between versions where the titles do not match.
|